BIOMAT Database Logo BIOMAT Database Logo

[Pharmacodynamics of digitalis glycoside in childhood. Comparative study of the bioavailability of digoxin and beta methyldigoxin]. 1977

F Arrigo, and S Consolo, and I Barberi, and C Melluso

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008520 Medigoxin A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE). Metildigoxin,beta-Methyldigoxin,4'''-O-Methyldigoxin,Bemecor,Lanirapid,Lanitop,Medixin,Methyldigoxin,4''' O Methyldigoxin,beta Methyldigoxin
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Comparative examinations of serum-glycoside concentrations in glycoside intoxications with extracardiac adverse effects after intake of beta-methyldigoxin, beta-acetyldigoxin and digoxin].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Digoxin therapy in patients with long-term digitalis therapy. Comparison of the digoxin blood level after oral administration of digoxin and beta-methyldigoxin].
March 1980, Fortschritte der Medizin,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Digitalis: from foxglove to beta-methyldigoxin].
March 1978, Pharmazie in unserer Zeit,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Proceedings: Comparative radioimmunological studies on renal elimination of digoxin and beta-methyldigoxin].
January 1975, Zeitschrift fur Kardiologie,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Comparative studies on renal and biliary excretion of digoxin and beta-methyldigoxin in man].
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Studies on the elimination of digoxin and beta-methyldigoxin].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
Bioavailability of digoxin and beta-methyl-digoxin.
January 1976, The Journal of international medical research,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
Comparative pharmacodynamics of betamethyl digoxin and digoxin in man.
September 1977, Clinical pharmacology and therapeutics,
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Pharmacology of pure glycoside digoxin obtained from Digitalis lanata].
August 1953, Deutsche medizinische Wochenschrift (1946),
F Arrigo, and S Consolo, and I Barberi, and C Melluso
[Comparative studies on the bioequivalency of digoxin (Lanoxin) and of beta-methyldigoxin (Lanitop) in patients with cardiac insufficiency].
January 1977, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
Copied contents to your clipboard!